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(e human microbiome comprises bacteria, archaea, viruses, and eukaryotes which reside within and outside our bodies. (ese
organisms impact human physiology, both in health and in disease, contributing to the enhancement or impairment of metabolic
and immune functions. Micro-organisms colonise various sites on and in the human body, where they adapt to specific features of
each niche. Facultative anaerobes are more dominant in the gastrointestinal tract, whereas strict aerobes inhabit the respiratory
tract, nasal cavity, and skin surface. (e indigenous organisms in the human body are well adapted to the immune system, due to
the biological interaction of the organisms with the immune system over time. An alteration in the intestinal microbial
community plays a major role in human health and disease pathogenesis.(ese alterations result from lifestyle and the presence of
an underlying disease. Dysbiosis increases host susceptibility to infection, and the nature of which depends on the anatomical site
involved.(e unique diversity of the humanmicrobiota accounts for the specific metabolic activities and functions of these micro-
organisms within each body site. It is therefore important to understand the microbial composition and activities of the human
microbiome as they contribute to health and disease.
1. Introduction
(e human microbiota is defined as a set of organisms
inhabiting and interacting with the human body [1]. (e
various interactions may be commensalistic, mutualistic, or
pathogenic. (e human microbiome is referred to as the
genomic content of organisms (microbiota) inhabiting a
particular site in the human body. micro-organisms colonise
various anatomical body sites such as the skin, the mucosa,
gastrointestinal tract, respiratory tract, urogenital tract, and
the mammary gland. (ey form a complex and discrete
ecosystem that adapts to the environmental conditions of
each niche [2]. From childbirth, a steady interaction
(symbiosis) between the human body and its indigenous
microbiota begins.(ese interactions play important roles in
maintaining general health and wellbeing. (rough coevo-
lution, organisms make up the microbiota, they actively
adjust to their specific habitats and reside in their respective
niches within the human body [3–5]. As a result of their
biological activities, these organisms are identified as part of
the body, leading to various changes from conception until
death. (e human microbiome is constantly evolving in
response to host factors. Factors such as age, nutrition,
lifestyle, hormonal changes, inherited genes, and underlying
disease are major determinants of the human microbiome at
any given point in time. However, an alteration in the
makeup of the human (dysbiosis) microbiota can lead to life-
threatening illnesses [2]. A balanced microbiota has shown
to play an important role in health sustenance [2]. (e
largest concentration of the human microbiome is found in
the gut. (ese organisms are the major players in main-
taining and sustaining the health of humans. Past studies on
the human microbiome project have illustrated that changes
in the immune environment may be directly linked to a
dysbiotic flora of the gut. Also, life-threatening health
conditions ranging from cancer, cardiovascular disease,
bowel inflammatory disease and difficult-to-treat bacterial
infections due to antibiotic resistance have also been linked
with dysbiosis. [6, 7].
In general, this work aims to review and discuss the
impact of the human microbiome on human disease and on
maintaining health.
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2. The Human Microbiome and Disease
2.1. Cancer. (e gut microbiota plays a significant role in
affecting the well being of its host [8]. Studies on the in-
terplay of microbial communities and their respective host
suggest that these organisms carry out biochemical activ-
ities influencing carcinogenesis, tumour development, and
response to immune therapy as shown in Figure 1 [8].
According to a well-studied model on factors that may
contribute to dysbiosis in the gut, continuous intra-ab-
dominal infections, antimicrobial drugs, or both may lead
to an increased risk of colorectal cancer. Also, end products
released by the gut microbiota affect the intestinal cell
coverage, encouraging carcinogenesis or suppressing
tumourigenesis [9]. Aside from colorectal cancer, the
microbiota of the intestinal tract has shown to play a role in
extraintestinal cancer such as hepatocellular carcinoma
through systematic dissemination of these organisms to
other parts of the body (Figure 2) [2]. In addition, H. pylori
contributes to the risk of gastric cancer in humans. Recent
findings on the interplay of the human microbiome and
cancer point out Fusobacterium and Clostridium being
overrepresented in individuals having gastric cancer [10].
In the case of breast cancer, environmental and host factors
directly influence the progression of cancer in the breast.
However, bacterial communities could also induce breast
cancer. Individuals with breast cancer have been more
likely to have Bacillus, members of the Enterobacteriaceae,
and Staphylococcus in their breast tissue as compared to
healthy individuals. Furthermore, Escherichia coli and
Staphylococcus epidermidis isolated from patients having
cancer triggered a double-stranded break in the DNA of
HeLa cells. Lactobacillus spp. which contributes to diverse
health benefits was not found in the breast tissue of in-
dividuals with breast cancer [11]. Prostate cancer has been
implicated with a higher population of Bacteroides mas-
siliensis. An alteration in the human microbiota has con-
tributed to the complex interactions between cancer and
the human microbiota [10].
2.2. InflammatoryBowelDisease (IBD). (e accumulation of
disease-causing organisms induces or triggers an abnormal
immune response against body tissues. (is, in fact, con-
tributes to autoimmune diseases, bowel inflammatory dis-
ease, and other life-threatening conditions [12]. Due to the
coevolution of the human microbiota and the immune
system, a balanced and systematic interaction occurs over
time. However, an alteration in the host-microbiota affects
this interaction leading to impairment in immune response
which may result in inflammatory disorder [13]. Sunil et al.
[14] describe the relationship of the gut microbiome with a
compromise in the integrity of the gastrointestinal barrier in
inflammatory bowel disease (IBD). Barrier around epithelial
cells forms a tight junction, which separates tissue space and
controls the movement of solutes across the epithelium. (e
barrier function of the intestine may be affected by a
damaged mucus layer, leading to a defective cell linkage
attachment [15]. A reduction in gut Firmicutes leads to
increased levels of proinflammatory cytokines (IL12, IFN-c)
and reduced anti-inflammatory cytokine (IL-10) levels [14].
Certain helminth infections were associated with anti-in-
flammatory organisms that prevent inflammatory bowel
disease in IBD susceptible mice [10].
2.3. Cardiovascular Diseases. Production of metabolites by
the gut microbiota does not only affect the gut but also act
systemically. (e production of trimethylamine N-oxide
(TMAO) metabolites by certain gastrointestinal organisms
may be implicated in heart disease [16]. (e gut microbiota
actively metabolizes trimethylamine from diets rich in
l-carnitine, choline, and phosphatidylcholine to trime-
thylamine N-oxide (TMAO) by hepatic flavins containing
monooxygenase. TMAO affects lipid transportation in the
body and also induces the release of precursors which
promote foam cell formation and hardening of the arteries
in animal models [16]. Intestinal dysbiosis has been dis-
covered to be associated with cardiovascular diseases. Kho
and Lal performed a clinical study on two categories of
individuals: individuals with low risk of cardiovascular
disease and those with a risk of cardiovascular disease. In
their findings, a disrupted intestinal flora was associated
with individuals having a higher risk of cardiovascular
disease [17, 18]. Overrepresentation of certain organisms
has been found to contribute to cardiovascular diseases.
Faecal transplants from hypertensive patients that had
overexpressed Prevotella and Klebsiella increased blood
pressure in germ-free mice animal models. Furthermore,
the faecal microbiota of hypertensive mice showed a sig-
nificant increase of the Firmicutes to Bacteriodetes ratio in
their stool [18, 19].
2.4. Systematic Infections Resulting from Bacterial
Translocation. Systematic infection occurs by the continu-
ous movement of bacteria in human hosts from the intes-
tinal mucosa to other extraintestinal sites as shown in
Figure 2. (e risk of a systemic disease from translocating
organisms is higher in immune-compromised individuals
who are hospitalized, undergoing surgery, or in trauma [19].
Damage in the epithelium of the gut and the abuse of an-
tibiotics disrupts the microbiota, leading to an increase in
facultative anaerobes and a defect in the host immune re-
sponses. Some examples of translocating organisms asso-
ciated with systemic infections include E. coli, K.
pneumoniae, Enterobacter spp., P. mirabilis, Enterococcus
spp., Streptococcus spp., and C. albicans [19]. In addition,
microbial translocation contributes to systemic infection by
the production of uremic toxins.(is discovery suggests that
an alteration in the microbiota of the gut may lead to the
synthesis of nitrogenous compounds which affect the in-
tegrity of the epithelial tight junction, allowing the transfer
of these organisms and its toxins to other parts of the body.
Uremic toxins produced by dysbiotic flora activate systemic
inflammatory responses which is a trigger to several diseases
[15]. In 2015, a clinical study discovered a link between gut
microbiota and chronic kidney disease. (ey observed the
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presence of translocation gut microbiota in individuals on
hemodialysis [16].
3. The Human Microbiome and
Allergic Diseases
Possible mechanism of the human microbiome in associa-
tion with allergic diseases has been identified [12]. Although,
little is known on the effects of the lungs microbiota on
immune regulation of the respiratory tract [20]. However,
the respiratory tract is greatly shaped by a balanced gut
microbiome that affects the mucosa of the lungs. A dysbiotic
flora directly affects the microbiome of the lungs through
microaspiration, and this increases the occurrence of re-
spiratory diseases in humans. Renz et al. illustrated this
finding in germ-free mice. Experimental mice were devoid of
an immune regulatory network which induced respiratory
and allergic diseases [21].
Caesarean (CS) delivery of neonates has also been
identified as a risk factor for allergic diseases. (e absence of
normal maternal flora during CS predisposes children to
such diseases [22]. Molecular-based studies have revealed
that CS-delivered children have lower counts of healthy flora
(Bacteriodetes) in their gut [6]. (is reduces the anti-in-
flammatory activities of Bacteriodetes and contributes to
local tissue inflammation (asthma and allergic rhinitis)
triggered by genetic and environmental factors [12]. A recent
epidemiological study reported a significant association
between dysbiotic gut flora and the production of allergic
antigen (IgE) resulting in airway disease in children [23].
Additional studies establish that children with lower mi-
crobial diversity of Bifidobacterium, Akkermansia, and
Faecalibacterium were susceptible to multiple allergen re-
spiratory sensitivity (polysensitisation) and may contribute
to asthma at the age of 4 [24]. A review by Huang et al.
further supports these findings. Germ-free mice were more
susceptible to allergic airway disease. After microbial col-
onization, the susceptibility was reversed and a reduced
allergen sensitivity was observed. Clinical studies on the
incidence of allergies in Europe showed that farming en-
vironments containing diverse microbial communities had a
lower rate of airway allergies [25]. (e mechanism behind
this phenomenon has been linked to the activation of the
innate immune system in the epithelial cell of the respiratory
tract. Exposure to farm dust containing microbial diversities
of Acinetobacter lwoffii F78 and Lactococcus lactis G121 has
proven to reduce respiratory inflammation in mice [25, 27].
4. The Human Microbiome in
Health Sustenance
4.1. Maintenance of Homeostasis. (e human microbiome
plays important roles in the maintenance and development
of the human body (Figure 3). (ese organisms are re-
sponsible for launching the immune system, affecting in-
flammatory homeostasis and immune regulation in
neonates and young children [14]. In 2015, Melli in his study
reviewed that children who develop allergies later in life were
identified to have a higher prevalence of Bacteroidaceae and
anaerobic bacteria with a lower count of Bifidobacterium
adolescentis, Bifidobacterium bifidum, and Lactobacillus spp.
[26, 27]. Continuous research studies on microbiome have
also identified that these organisms interact with and de-
grade external contaminants such as heavymetals, polycyclic
aromatic hydrocarbons, pesticides, ochratoxins, plastic
monomers, and organic compounds [28]. Following renal
filtration in the kidney, the toxins removed from the
bloodstream are stored within the bladder which provides
substrates and a conducive environment for the urinary tract













Figure 1: Dysbiotic flora and its impact on human health. Carcinogenic metabolic toxins produced from dysbiotic flora may trigger the
progression of cancer and immune reaction in the gastrointestinal tract. In addition, hepatic oxidation of trimethylamine to trimethylamine
N-oxide contributes to cardiovascular and emerging diseases.
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of these organisms interplay in the outcome of an infection.
In the female genital tract, the protective mechanism is
initiated by indigenous microbial flora which is responsible
for inducing innate immunity, including the secretions
containing cytokines, antimicrobial peptides, and inhibitory
substances [29].
4.2. Development of Host Immune System. (rough coevo-
lution of indigenous microbiota and the immune system,
immune responses are developed and enhanced by the
immune system’s ability to differentiate between harmful
pathogens and commensal organisms that must be main-
tained [30]. In the gut, the composition of the microbiota
influences the developmental aspects of the adaptive
immune system; therefore, the mammalian immune sys-
tem, which is responsible for controlling micro-organisms,
is shaped by the human microbiota [13]. In recent studies
on the functions of the human microbiome, it has been
illustrated that the absence of these organisms or early
alteration of commensal organisms may result in exacer-
bated type II immunity and allergies as a result of an ab-
normal immune functionality. In children, for example,
alterations to the microbiota through epigenetic influences
such as caesarean births, an increasingly sedentary lifestyle,
environmental pollution, andWestern-type diets have been
linked with an increase in cases of childhood allergic
rhinitis [7, 22]. Probiotics, breastfeeding, lifestyle changes
such as allowing children to play out in the morning
sunshine (to promote vitamin D production), and allergen-
Pathogenic invasion
Systemic dissemination of bacteria
in the body 
Figure 2: An alteration in the gut microbiota leads to systemic translocation of organisms from damaged gut epithelium to other
extraintestinal sites.
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specific immunotherapy have been proposed as factors
promoting the development of the immune system of and the
prevention of atopy in children [22]. (e gut microbiota is
responsible for activating the proinflammatory (17cells and
regulatory T-cells (Tregs) in the intestine [10]. In addition, the
human microbiota has significant influence on innate im-
munity. An example is neutrophil ageing which reduces
proinflammatory properties in the body [30]. (ese organ-
isms stimulate neutrophil ageing through Toll-like receptor-
(TLR-) and MyD88-mediated signalling pathways. Microbial
alteration leads to reduced circulation of aged neutrophils and
in return results in inflammation-related organ damage in
models of sickle cell disease or endotoxin-induced septic
shock. (erefore, these organisms actively control disease-
promoting neutrophil which is necessary for inflammatory
diseases [30]. Furthermore, the intestinal microbiota helps in
the defence against pathogenic organisms. (ey promote
colonization resistance and the synthesis of antimicrobial
compounds against invading pathogens. For example, a
balanced gut microbiome may be responsible for regulating
antibodies (CD8-T cells and CD4 cells) which respond to the
invasion of influenza virus in the respiratory tract [12]. Also,
the intestinal microbiota helps to improve and maintain the
gastrointestinal functions [31]. (e high concentration of
organisms in the gut remains a problem to the intestinal
immune system, as the immune system needs to accept
commensal microbiota and dietary antigens while also
retaining its ability to eradicate pathogens. (e activation of
colonic regulatory T-cells (Tregs) is important in developing
immune homeostasis [14]. (ere are two types of Tregs: the
thymus-derived and peripherally derived Tregs (pTregs).
(ere is complexity in the differentiation of these two im-
mune responses, but they have an essential role in immune
regulation [14]. However, the pTregs, in particular, require
microbiota to be active in the colon.
4.3. Host Nutrition. (e colonic microbiota makes signifi-
cant contributions to the nutritional requirements of their
host [32]. (ese organisms actively break down complex
dietary constituents that are indigestible (complex carbo-
hydrates) by the intestinal cells making complex food ma-
terials readily available for absorption and assimilation. In
the digestive tract, major end products of carbohydrates and
amino acids are the short-chain fatty acids (SCFAs) which
include acetic, propionic, and butyric acids [33]. (ese three
dietary constituents, upon absorption by colonic mucosa,
serve as energy sources and precursors for the synthesis of
mucosal lipids and stimulate cell growth of the epithelial cell
resulting in maintenance of gut integrity [19]. Colonic
microbiota protects the large bowel against cancer by the
production of butyrate from the fermentation of complex
dietary constituents [9]. (ese important microbial activities
in the colon have resulted in the provision of essential
nutrients which are not readily accessible but are required
for colonic health sustenance [33]. In Africa, mothers and
infants have been discovered to contain a high level of
Bacteriodetes and SCFAs in their stool as compared with the
European infants whose mothers consume Western diets
low in SCFAs. Studies have shown that the consumption of
traditional and fermentable carbohydrate may have con-
tributed to the prevalence of healthy gut microbiome [12].
Another important function of the colonic microbiota is the
provision of vitamins necessary for host development. In-
testinal bacteria such as Bifidobacterium spp., Bacteroides
spp., and enterobacteria are responsible for the production
of vitamins [32]. Vitamin K, for instance, is an important
coenzyme responsible for the synthesis of several clotting
factors which include prothrombin (a deficiency of this leads
to delayed blood clotting and excessive bleeding). Also, folic
acid is an important precursor for DNA and RNA synthesis.
Finally, they are involved in the synthesis of red and white
blood cells [19]. Today, probiotics containing lactobacillus or
Bifidobacterium are used in treatments of allergic diseases.
Findings from the use of probiotics as treatment options
have revealed that an enhanced immunomodulatory effect is
achieved by reducing or inhibiting antigen-inducing T-cell
activation and also suppressing cell signalling protein (tu-










Figure 3: Symbiotic interaction between eubiotic flora and the human body results in the maintenance of homeostasis, regulation, and
development of the immune system, hosts nutrition, and colonization resistance.
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5. Conclusion and Recommendation
(e study of the human microbiome is important, and it
gives an in-depth understanding of the interplay between
humans and its indigenous microbiota. (is gives valuable
insight into further research studies in optimizing these
organisms to combating life-threatening diseases. It is im-
portant to note that the continuous use of broad-spectrum
antibiotics may disrupt the human microbiota. (is results
in an imbalance of the indigenous microbial community
paving way for invading pathogens. However, treatments
with the use of pre and probiotics should be encouraged.
Hence, more research should be focused on the use of
probiotic therapy in the treatment of infectious disease. In
addition, further studies should emphasize on the effects of
the human microbiome on mental health and also the
impacts of mycobiome and the virome community on in-
digenous microbiota as they may contribute to dysbiosis.
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